Abeona Therapeutics Joins Rare Disease Company Coalition

Abeona Therapeutics Inc. (Nasdaq: ABEO) has recently become a member of the Rare Disease Company Coalition (RDCC), a coalition consisting of life science companies that are committed to developing therapies for rare diseases. Vish Seshadri, the CEO of Abeona, has also been appointed to the RDCC's Board of Directors. Abeona is thrilled to join forces with the RDCC and shares their dedication to a..